NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
PMCB PharmaCyte Biotech
- 1.764
- +0.014+0.80%
Close Feb 28 16:00 ET
- 1.764
- 0.0000.00%
Post 20:01 ET
12.29MMarket Cap2.00P/E (TTM)
1.840High1.697Low26.73KVolume1.800Open1.750Pre Close48.19KTurnover0.43%Turnover RatioLossP/E (Static)6.97MShares2.58052wk High0.28P/B11.01MFloat Cap1.39052wk Low--Dividend TTM6.24MShs Float9.980Historical High--Div YieldTTM8.18%Amplitude1.390Historical Low1.803Avg Price1Lot Size
PharmaCyte Biotech Key Stats
Quarterly+Annual
YOY
| (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 46.85%-1.05M | -208.85%-373.3K | 43.29%-2.15M | -15.45%-332.96K | 67.31%-177.1K | -5.59%-1.98M | 131.63%342.96K | 7.86%-3.79M | 75.80%-288.39K | -81.39%-541.7K |
| Net income from continuing operations | -152.67%-1.47M | 835.76%23.42M | 107.73%333.76K | 1,165.95%1.35M | 18.92%-619.54K | 248.36%2.79M | -106.04%-3.18M | -1.81%-4.32M | 91.12%-126.34K | 5.81%-764.14K |
| Operating gains losses | 6.68%-3.09M | -1,269.21%-23.17M | ---4.17M | ---2.62M | ---230K | ---3.31M | --1.98M | ---- | ---- | ---- |
| Other non cash items | ---- | ---- | -212.05%-195K | ---- | ---- | ---- | 40,007.11%913.64K | 399.40%174.02K | 91.21%5.88K | 6,692.30%165.87K |
| Change In working capital | 18.98%-449.33K | -80.07%125.67K | 200.58%298.89K | 151.90%87.15K | 123.67%135.74K | -7,954.17%-554.61K | 39.82%630.62K | -3,387.23%-297.17K | -175.60%-167.93K | -215.94%-573.37K |
| -Change in prepaid assets | -7.87%-252.99K | 2.85%19.57K | -1,026.06%-152.12K | -48.23%37.96K | -66.46%25.43K | -2.57%-234.54K | -71.18%19.03K | 35.80%-13.51K | -8.26%73.33K | 11.97%75.8K |
| -Change in payables and accrued expense | 38.66%-196.34K | -82.65%106.1K | 259.00%451.01K | 120.39%49.19K | 116.99%110.31K | -244.32%-320.07K | 58.86%611.59K | -1,033.17%-283.66K | -269.66%-241.25K | -252.08%-649.17K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 46.85%-1.05M | -208.85%-373.3K | 43.29%-2.15M | -15.45%-332.96K | 67.31%-177.1K | -5.59%-1.98M | 131.63%342.96K | 7.86%-3.79M | 75.80%-288.39K | -81.39%-541.7K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -7M | -5M | 0 | -5M | 0 | 0 | 0 | 0 | |
| Net investment purchase and sale | --0 | ---7M | ---5M | --0 | ---5M | --0 | --0 | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---7M | ---5M | --0 | ---5M | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -1,534.56%-10.74M | -261.99%-10.17M | 21.03%-10.71M | -148.38%-10.7M | -86.31%-7.04M | 122.12%748.69K | 400.44%6.28M | -115.53%-13.56M | -8,376.76%-4.31M | -3.78M |
| Net common stock issuance | -750.87%-1.4M | 97.19%-742.18K | -107.94%-28.2M | 72.73%-1.17M | 89.39%-400.71K | 95.13%-164.95K | -1,165.39%-26.46M | -115.52%-13.56M | -113.60%-4.31M | ---3.78M |
| Net preferred stock issuance | -591.66%-9.34M | -126.94%-9.43M | --17.49M | ---9.52M | ---6.64M | ---1.35M | --35M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | -92.05%70 | --0 | --0 | --0 | -92.05%70 | --880 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---2.26M | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -1,534.56%-10.74M | -261.99%-10.17M | 21.03%-10.71M | -148.38%-10.7M | -86.31%-7.04M | 122.12%748.69K | 400.44%6.28M | -115.53%-13.56M | -8,376.76%-4.31M | ---3.78M |
| Net cash flow | ||||||||||
| Beginning cash position | -56.29%32.64M | -26.25%50.18M | -20.33%68.04M | -15.73%61.21M | -4.60%73.43M | -9.20%74.66M | -20.33%68.04M | 3,778.14%85.4M | -16.16%72.64M | -11.47%76.96M |
| Current changes in cash | -854.55%-11.8M | -364.95%-17.55M | -2.92%-17.86M | -140.04%-11.03M | -182.79%-12.22M | 76.53%-1.24M | 308.61%6.62M | -120.86%-17.35M | -269.78%-4.6M | -1,346.47%-4.32M |
| Effect of exchange rate changes | 103.83%61 | -59.42%183 | 92.99%-508 | 91.70%-438 | 141.90%1.07K | -120.97%-1.59K | -65.41%451 | -256.67%-7.25K | -248.87%-5.28K | -1,116.19%-2.55K |
| End cash Position | -71.62%20.84M | -56.29%32.64M | -26.25%50.18M | -26.25%50.18M | -15.73%61.21M | -4.60%73.43M | -9.20%74.66M | -20.33%68.04M | -20.33%68.04M | -16.16%72.64M |
| Free cash flow | 46.85%-1.05M | -208.85%-373.3K | 43.29%-2.15M | -15.45%-332.96K | 67.31%-177.1K | -5.59%-1.98M | 131.63%342.96K | 7.86%-3.79M | 75.80%-288.39K | -81.39%-541.7K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |